
|Articles|June 1, 2004
- BioPharm International-06-01-2004
- Volume 17
- Issue 6
Site Expansion - Regional Roundup: Georgia
Regional Roundup: Georgia
Advertisement
Key cities and populations
Metropolitan Statistical Areas: Atlanta: 4,529,256; Augusta-Richmond County, GA-SC: 507,000; Savannah: 300,000; Columbus, GA-AL: 283,000; Macon: 224,846; Athens-Clarke County: 170,012
Targeted industries
Biosciences (oncology, cardiovascular, infectious disease, bio-nanotechnology), logistics, advanced telecommunications, software
Biopharm employment
10,000 private sector; 12,000 government & academia
Academia affiliated with biopharm industry
Emory University; Georgia State University; University of Georgia; Georgia Institute of Technology; Clark Atlanta University; Morehouse School of Medicine; Medical College of Georgia; Kennesaw State University; Mercer University
Primary business strengths
Business center of Southeast US; low cost of living and low cost of business; country's largest in-migration for Metro Atlanta; world's largest and busiest passenger airport; highly educated workforce; public health capital with headquarters for CDC, American Cancer Society, Arthritis Foundation, Carter Center, and other centers
Tax and other incentives
Customized competitive incentive packages; state bioscience seed fund; various tax credits; state research funding via Georgia Research Alliance and Georgia Cancer Coalition; QuickStart customized state-funding training program
BioClusters
Metro Atlanta: over 75% of industry located in Metro Atlanta, primarily within the city and northern suburbs. Approximately 150 bioscience companies;
Athens-Clarke County: approximately 15 companies, many affiliated with University of Georgia;
Augusta-Richmond County: new bioscience incubator emerging at Medical College of Georgia
State commitment to biopharm industry and future plans for its growth
Over $350 million in state-supported research via Georgia Research Alliance; $1 billion Georgia Cancer Coalition; state Bioscience Seed Capital Fund; dedicated Office of Science and Technology; customized biopharm training paid by state QuickStart program; various industry funding programs via University System of Georgia; initiatives to continue statewide industry growth include several planned bio-parks in metro Atlanta, Augusta, and Athens; over 20,000 biopharm private sector employees expected by 2010
State- and regional-level contacts
Georgia Biomedical Partnership
Articles in this issue
over 21 years ago
Site Expansion - Regional Round-Up: Floridaover 21 years ago
A Protocol for Trademark Protectionover 21 years ago
Technology Licensing — From First Steps to Executing a Planover 21 years ago
Integrating QSIT into Quality Plansover 21 years ago
Big Pharma And Investors Eye Australian Bio-Innovation Powerhouseover 21 years ago
Correlating the Results from Chemistry Analyzersover 21 years ago
Regulatory Beat: FDA: Manufacturing Innovation Can Boost R&Dover 21 years ago
Final Word: PEGylation — A "Sunset" Technology?over 21 years ago
Wall Street Gets PersonalNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement